ABVC BioPharma, Inc.
ABVC
$1.23
-$0.08-6.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 138.20% | 23.54% | 126.75% | 104.23% | 124.44% |
| Total Receivables | -33.91% | 121.53% | 11.97% | -40.32% | 52.07% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 260.29% | 389.92% | 93.45% | -39.60% | -4.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.89% | 4.63% | 11.25% | -3.36% | -6.27% |
| Total Current Assets | 14.75% | 89.57% | 26.53% | -18.11% | 31.57% |
|
|
|||||
| Total Current Assets | 14.75% | 89.57% | 26.53% | -18.11% | 31.57% |
| Net Property, Plant & Equipment | 1,180.83% | 47.23% | 1.62% | 0.52% | -16.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.83% | 25.45% | 27.93% | 26.70% | -12.23% |
| Total Assets | 179.34% | 46.42% | 10.98% | 2.87% | -3.14% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 8.39% | -4.29% | -6.35% | -4.13% | -5.43% |
| Short-term Debt | -48.32% | 56.69% | 27.08% | 35.41% | 59.15% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.35% | -61.79% | -52.98% | -2.61% | 3.82% |
| Total Finance Division Other Current Liabilities | 68.73% | 117.10% | 94.59% | -8.66% | 4.25% |
| Total Other Current Liabilities | 68.73% | 117.10% | 94.59% | -8.66% | 4.25% |
| Total Current Liabilities | -6.00% | 3.04% | -0.25% | 1.46% | 7.47% |
|
|
|||||
| Total Current Liabilities | -6.00% | 3.04% | -0.25% | 1.46% | 7.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -48.32% | 56.69% | 27.08% | 35.41% | 59.15% |
| Capital Leases | 575.97% | 15.40% | -22.60% | -47.52% | -41.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -53.31% | 50.54% | 0.00% | 0.00% |
| Total Liabilities | 13.92% | 3.09% | -0.79% | -0.77% | 4.36% |
|
|
|||||
| Common Stock & APIC | 22.17% | 6.66% | -0.80% | -2.80% | 6.25% |
| Retained Earnings | -11.47% | -3.89% | -2.39% | -0.63% | -7.66% |
| Treasury Stock & Other | 4.39% | 7.42% | 13.04% | 5.17% | -0.57% |
| Total Common Equity | 806.28% | 44.26% | -15.43% | -30.64% | -21.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 806.28% | 44.26% | -15.43% | -30.64% | -21.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 535.21% | 742.34% | 632.27% | 936.41% | -67.07% |
| Total Equity | 1,736.67% | 81.63% | 21.22% | 6.27% | -42.24% |
|
|
|||||